Legal Opinion
AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC.
District Court, D. Delaware
Decided January 11, 2023No. 1:21-cv-01286Unknown
1Opinion
INTHEUNITEDSTATESDISTRICTCOURT FORTHEDISTRICTOFDELAWARE AZURITYPHARMACEUTICALS,INC., Plaintiff, CivilAction v. Nos. 21-cv-1286,21-cv-1455 BIONPHARMAINC., Defendant. MEMORANDUMOPINION Goldberg, J.1 January 11, 2023 These cases comprise what the parties refer to as the “Third Wave” in an ongoing patent infringement dispute between Plaintiff Azurity Pharmaceuticals, Inc. (“Azurity”) and Defendant Bionpharma Inc. (“Bionpharma”). The parties’ dispute revolves around Bionpharma’s generic enalapril oral liquid. Bionpharma’s counterclaims assert antitrust “sham litigation” claims under the Sherman…
2Cases cited11 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Professional Real Estate Investors, Inc. v. Columbia Pictures Industries, Inc.Supreme Court of the United States · 1993
- Atlantic Richfield Co. v. USA Petroleum Co.Supreme Court of the United States · 1990
- Mercoid Corp. v. Mid-Continent Investment Co.Supreme Court of the United States · 1944
6 more not listed; retrieve them via the Exa API.